Astec Lifesciences
Ticker >

Astec Lifesciences share price

Astec Lifesciences Ltd.

NSE: ASTEC BSE: 533138 SECTOR: Pesticides & Agrochemicals  48k   345   21

1235.00
-30.65 (-2.42%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 1264.5

Today's Low

₹ 1225.45

52 Week High

₹ 1540

52 Week Low

₹ 826.15

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 2421.74 Cr.

Enterprise Value

₹ 2761.54 Cr.

No. of Shares

1.96 Cr.

P/E

0

P/B

6.54

Face Value

₹ 10

Div. Yield

0.12 %

Book Value (TTM)

₹  188.72

CASH

₹ 1.38 Cr.

DEBT

₹ 341.18 Cr.

Promoter Holding

66.75 %

EPS (TTM)

₹  -26.01

Sales Growth

-7.15%

ROE

6.27 %

ROCE

7.75%

Profit Growth

-71.59 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-7.15%
3 Year6.35%
5 Year11.12%

Profit Growth

1 Year-71.59%
3 Year-18.69%
5 Year-6.11%

ROE%

1 Year6.27%
3 Year18.38%
5 Year19.12%

ROCE %

1 Year7.75%
3 Year17.4%
5 Year18.58%

Debt/Equity

0.8154

Price to Cash Flow

32.58

Interest Cover Ratio

2.68027637282366

CFO/PAT (5 Yr. Avg.)

1.03940403239044

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 66.75 0
Sep 2023 66.75 0
Jun 2023 66.76 0
Mar 2023 66.77 0
Dec 2022 66.77 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.663293232305761.
  • The company has a high promoter holding of 66.75%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.6754497140269.

 Limitations

  • The company has shown a poor profit growth of -18.6888155052745% for the Past 3 years.
  • The company has shown a poor revenue growth of 6.3505738865979% for the Past 3 years.
  • Company has contingent liabilities of 202.8574 Cr.
  • The company is trading at a high PE of 0.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 117.18 126.97 142.85 110.79 50.79
Total Expenditure 105.05 121.57 139.71 114.21 69.12
Operating Profit 12.13 5.4 3.14 -3.42 -18.33
Other Income 3.78 2.57 1.7 0.96 0.9
Interest 5.88 6.41 6.47 6 6.1
Depreciation 8.81 7.78 9.4 9.17 8.72
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.21 -6.21 -11.03 -17.64 -32.25
Tax 0.39 -1.22 -2.83 -4.19 -7.9
Profit After Tax 0.83 -5 -8.21 -13.45 -24.35
Adjusted EPS (Rs) 0.42 -2.55 -4.19 -6.86 -12.42

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 430.9 522.22 554.87 676.57 628.17
Total Expenditure 354.49 437.02 443.47 522.48 551.9
Operating Profit 76.41 85.2 111.4 154.08 76.27
Other Income 11.1 11.93 7.78 10.46 13.04
Interest 12.38 12.64 4.79 9.09 20.74
Depreciation 19.34 23.22 25.71 34.42 33.71
Exceptional Items 0 0 0 0 0
Profit Before Tax 55.79 61.27 88.67 121.04 34.85
Tax 20.11 13.8 23.98 31.22 9.33
Net Profit 35.69 47.47 64.69 89.82 25.52
Adjusted EPS (Rs.) 18.25 24.26 33.03 45.83 13.02

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 19.55 19.57 19.59 19.6 19.61
Total Reserves 182.91 226.87 289.12 376.38 399.19
Borrowings 0 0 40 0 10.86
Other N/C liabilities 9.46 6.78 6.23 38.28 22.86
Current liabilities 249.16 318.88 322.97 491.07 526.33
Total Liabilities 461.09 572.1 677.9 925.32 978.85
Assets
Net Block 166.64 193.68 212.67 339.88 318.35
Capital WIP 18.63 22.11 111.68 13.73 112.38
Intangible WIP 0.35 2 4.04 9.09 14.22
Investments 0.49 0.49 0.43 0.43 0.43
Loans & Advances 26.57 22.13 18.66 46.81 35.37
Other N/C Assets 0 0 0 0 0
Current Assets 248.4 331.69 330.43 515.38 498.09
Total Assets 461.09 572.1 677.9 925.32 978.85
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 55.79 61.27 88.67 121.04 34.85
Adjustment 30.33 37.57 29.52 44.11 50.61
Changes in Assets & Liabilities -54.4 87.92 -103.26 -112.61 -6.28
Tax Paid -16.41 -18.2 -22.99 -29.13 -4.86
Operating Cash Flow 15.33 168.56 -8.06 23.41 74.32
Investing Cash Flow -52.5 -73.81 -73.11 -103.57 -112.07
Financing Cash Flow 37.09 -94.64 81.23 80.37 37.66
Net Cash Flow -0.08 0.11 0.06 0.22 -0.09

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 66.77 66.77 66.76 66.75 66.75
ashok vishwanath hiremath... 1.99 1.99 1.99 1.99 1.99
godrej agrovet limited 64.77 64.77 64.77 64.76 64.76
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 33.23 33.23 33.24 33.25 33.25
icici prudential multicap... 3.13 3.96 4.55 5.30 5.30
investor education and pr... 0.05 - - 0.05 0.05
kaushik daga 2.03 2.01 2.01 1.67 1.67
nippon life india trustee... 3.70 3.70 3.70 3.70 3.32
shreans daga 1.94 1.60 1.60 1.94 1.90
motilal oswal india excel... - 1.01 1.01 1.01 -
government pension fund g... 1.43 1.43 1.40 - -
investor education and pr... - 0.05 0.05 - -
own infracon private limi... 1.06 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Astec LifeSciences informs about closure of trading window19 Apr 2024, 11:01AM Astec Lifesciences - Quaterly Results25 Jan 2024, 4:46PM Astec Lifesciences - Quaterly Results25 Jan 2024, 4:46PM Astec Lifesciences - Quaterly Results25 Jan 2024, 4:46PM Astec Lifesciences informs about compliances-certificate 11 Jan 2024, 12:58PM Astec Lifesciences - Quaterly Results27 Oct 2023, 5:05PM Astec Lifesciences - Quaterly Results27 Oct 2023, 5:05PM Astec Lifesciences - Quaterly Results27 Oct 2023, 5:05PM Astec Lifesciences raises Rs 49 crore through NCDs23 Aug 2023, 9:25AM Astec Lifesciences informs about disclosure 2 Aug 2023, 2:31PM Astec Lifesciences - Quaterly Results27 Jul 2023, 3:18PM Astec Lifesciences - Quaterly Results27 Jul 2023, 3:18PM Astec Lifesciences - Quaterly Results27 Jul 2023, 3:18PM Astec Lifesciences - Quaterly Results2 May 2023, 5:51PM Astec Lifesciences - Quaterly Results2 May 2023, 5:51PM Astec Lifesciences - Quaterly Results2 May 2023, 5:51PM Astec LifeSciences launches R&D Center in Rabale11 Apr 2023, 2:58PM Astec Lifesciences gets nod to raise Rs 50 crore via NCDs 31 Jan 2023, 12:59PM Astec Lifesciences - Quaterly Results30 Jan 2023, 5:10PM Astec Lifesciences - Quaterly Results30 Jan 2023, 5:10PM Astec Lifesciences - Quaterly Results30 Jan 2023, 5:10PM Astec Lifesciences informs about outcome of board meeting29 Oct 2022, 11:49AM Astec Lifesciences - Quaterly Results28 Oct 2022, 4:37PM Astec Lifesciences - Quaterly Results28 Oct 2022, 4:37PM Astec Lifesciences - Quaterly Results28 Oct 2022, 4:37PM Astec Lifesciences informs about disclosure14 Oct 2022, 5:08PM Astec LifeSciences submits newspaper advertisement17 Aug 2022, 4:53PM Astec Lifesciences informs about postal ballot notice17 Aug 2022, 12:28PM Astec Lifesciences - Quaterly Results25 Jul 2022, 3:48PM Astec Lifesciences - Quaterly Results25 Jul 2022, 3:48PM Astec Lifesciences - Quaterly Results25 Jul 2022, 3:48PM Astec LifeSciences informs about disclosure of related party transactions14 Jun 2022, 3:21PM Astec Lifesciences - Quaterly Results2 May 2022, 5:13PM Astec Lifesciences - Quaterly Results2 May 2022, 5:13PM Astec Lifesciences - Quaterly Results2 May 2022, 5:13PM Astec Lifesciences informs about disclosure29 Mar 2022, 4:11PM Astec LifeSciences informs about board meeting18 Jan 2022, 4:32PM Astec LifeSciences informs about conference call27 Jul 2021, 12:16PM Astec LifeSciences informs about 28th AGM2 Jul 2021, 4:25PM Astec Lifesciences informs about trading window closure31 Dec 2020, 4:23PM Astec LifeSciences informs about disclosure19 Sep 2020, 11:12AM Astec Lifesciences sells entire equity stake in Astec Europe Sprl1 Sep 2020, 10:50AM Astec Lifesciences informs about clarification on price movements26 Jun 2020, 10:31AM Astec LifeSciences informs about analsyt meet18 May 2020, 11:19AM

Astec Lifesciences Stock Price Analysis and Quick Research Report. Is Astec Lifesciences an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a LOW P/E are undervalued (it depends on other factors too). Astec Lifesciences has a PE ratio of -47.7733213869587 which is low and comparatively undervalued .

  • Share Price: - The current share price of Astec Lifesciences is Rs 1242.35. One can use valuation calculators of ticker to know if Astec Lifesciences share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Astec Lifesciences has ROA of 2.68047678758715 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Astec Lifesciences has a Current ratio of 0.94635488360384 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Astec Lifesciences has a ROE of 6.26940965417452 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Astec Lifesciences has a D/E ratio of 0.8154 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Astec Lifesciences has an Inventory turnover ratio of 2.62033885429481 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Astec Lifesciences has reported revenue growth of -7.15375777769534 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Astec Lifesciences for the current financial year is 12.1408951962076 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Astec Lifesciences is Rs 1.5 and the yield is 0.121 %.

Last Updated on:
Brief about Astec Lifesciences

Astec LifesciencesLtd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Astec Lifesciences Ltd. is a leading Indian pharmaceutical company committed to providing high-quality products to customers. The company specializes in the manufacturing and marketing of agro-chemicals, pharmaceutical intermediates, and specialty chemicals.

Astec Lifesciences Ltd. Share Price

Astec Lifesciences Ltd. is a publicly traded company listed on the BSE and NSE. The stock's current market price can be checked on our website's Astec Lifesciences Ltd. stock analysis page. We provide real-time stock prices that are updated every few minutes throughout the trading day.

Astec Lifesciences Ltd. Balance Sheet

Astec Lifesciences Ltd. balance sheet is an important tool for investors to analyze the company's financial standing. Our website's Astec Lifesciences Ltd. stock analysis page provides access to the company's annual reports and quarterly financial statements. Using our premium feature like DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, investors can calculate the fair value of the company.

Astec Lifesciences Ltd. Annual Report

Astec Lifesciences Ltd. annual reports provide a comprehensive overview of the company's performance over the year. Our website provides downloadable annual reports that include the company's financial statements, management discussion, and analysis of the company's operations. Investors can use our pre-built screening tools to compare the company's performance with its peers.

Astec Lifesciences Ltd. Dividend

Astec Lifesciences Ltd. has a consistent track record of paying dividends to its shareholders. Our website's Astec Lifesciences Ltd. stock analysis page provides information on the company's dividend history. You can also set up a customized alert on our website to get notified when the company declares a dividend.

Astec Lifesciences Ltd. Quarterly Result

Astec Lifesciences Ltd. quarterly financial statements provide insights into the company's short-term performance. Our website provides downloadable quarterly results that include the company's income statement, balance sheet, and cash flow statement. Using our premium feature, investors can calculate important profitability ratios and compare them with the industry.

Astec Lifesciences Ltd. Stock Price

Astec Lifesciences Ltd. stock price can be monitored using our real-time stock price tracker on our website's stock analysis page. Our users can view the company's historical stock prices and set up customized alerts to track price changes.

Astec Lifesciences Ltd. Price Chart

Astec Lifesciences Ltd. price charts are a graphical representation of the company's stock price movements over a specific period. Our website's Astec Lifesciences Ltd. stock analysis page provides users with interactive price charts that can be customized by the user to display various technical indicators.

Astec Lifesciences Ltd. News

Our website provides the latest news and alerts related to Astec Lifesciences Ltd. The news section of our Astec Lifesciences Ltd. stock analysis page provides news stories related to the company from various trusted sources.

Astec Lifesciences Ltd. Concall and Transcripts

Astec Lifesciences Ltd. conference call transcripts provide users with detailed information on the company's internal workings. Our website provides downloadable transcripts from past calls that include management discussions on the company's performance and future plans.

Astec Lifesciences Ltd. Investor Presentations

Astec Lifesciences Ltd. investor presentations provide information on the company's strategy, financial performance, and future plans. Users can download these presentations from our website and use them to better understand the company's operations.

Astec Lifesciences Ltd. Promoters

Astec Lifesciences Ltd. promotes a shareholder-friendly culture that is reflected in its consistent dividend payouts and transparency in reporting. Our website's Astec Lifesciences Ltd. stock analysis page provides users with information on the company's promoters.

Astec Lifesciences Ltd. Shareholders

Astec Lifesciences Ltd. is owned by a diverse group of shareholders that include institutional investors and retail investors. Our website's Astec Lifesciences Ltd. stock analysis page provides users with information on the company's major shareholders and changes in their shareholding pattern.

Overall, our website's Astec Lifesciences Ltd. stock analysis page provides investors with detailed information on the company's performance, financial statements, and news. Our pre-built screening tools and premium features allow investors to evaluate the company's performance and calculate its fair value.

Read More
X